ComputeGenomics

Noida, India Founded: 2023 • Age: 3 yrs
A specialized platform for high-throughput genomics data analysis, enabling efficient processing for researchers and enterprises.

About ComputeGenomics

ComputeGenomics is a company based in Noida (India) founded in 2023. It operates as a B2B. ComputeGenomics operates in a competitive market with competitors including Biomodal, Aligned Bio, Singular Bio, YouScript and HAWK Biosystems, among others.

Key Metrics
  • Annual Revenue
    ₹0.13 Cr

    FY 2025 · -36% YoY

  • Net Loss
    -₹0.13 Cr

    FY 2025 · -101% margin

  • EBITDA
    -₹0.10 Cr

    FY 2025 · -79% margin

  • Employee Count
    1

Board of directors of Computegenomics Private Limited (ComputeGenomics)

Computegenomics Private Limited is the primary company behind ComputeGenomics. The board of Computegenomics Private Limited currently have 2 directors; the longest-serving is Himani Kaushik, appointed in 2023.

DirectorDesignationAppointedTenureEntity
Himani Kaushik
DIN 09510201
Director13 Jan 20233 yrs 8 moComputegenomics Private Limited
Kapil Ravi
DIN 07661925
Director13 Jan 20233 yrs 8 moComputegenomics Private Limited

Financials of ComputeGenomics

Figures of Computegenomics Private Limited, the primary company behind ComputeGenomics, for FY 2025. Revenue was ₹0.13 Cr (-36% year on year). Net loss was -₹0.13 Cr (-101% margin). EBITDA was -₹0.10 Cr (-79% margin).

  • ₹0.13 CrRevenue · FY 2025 · -36% YoY
  • -₹0.13 CrNet loss · -101% margin
  • -₹0.10 CrEBITDA · -79% margin
  • ₹0.01 CrPaid-up capital

Balance sheet, profit and loss, cash flow and ratios of Computegenomics Private Limited are on its company page.

Premium access

Detailed financial statements for ComputeGenomics

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of ComputeGenomics

ComputeGenomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biomodal, Aligned Bio, Singular Bio, YouScript and HAWK Biosystems, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
biomodal.com2012Cambridge, United Kingdom$164.1M–
Developer of DNA sequencing tools and technology for research and diagnostics
alignedbio.com2019Lund, Sweden$908,526–
Nanowire-based sensors and alignment technologies are provided for molecular detection.
singularbio.com2012San Francisco, United States$6.6M–
Tools for single molecule detection are developed by Singular Bio.
youscript.com2000Seattle, United States–14
Clinical decision support software for drug interactions is developed.
hawkbiosystems.com2015Derio, Spain––
Clinical assays are developed for quantifying novel biomarkers in samples.
nooma.bio2020Santa Cruz, United States–14
Dual-nanopore technology is developed for genome-wide structural and epigenetic variations.
annogen.bio2019Amsterdam, Netherlands––
Genetic variations are screened via a specialized genomic platform.
dnatechnologies.com1993Los Angeles, United States––
Anti-counterfeiting and brand protection solutions are delivered via DNA-laced markers.
geospiza.com1997Seattle, United States$4.8M–
Enterprise software systems for genetic analysis workflows are developed.
acuityspatialgenomics.com2020Watertown, United States––
A 3D genomics platform is developed for multi-omic analyses.
Premium access

Detailed competitors of ComputeGenomics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Similar companies to ComputeGenomics

10 companies that operate in the same segment as ComputeGenomics (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M2,020
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 3.22 BUSD 147.17 M1,000
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits
2006Sunnyvale, California, United StatesUSD 943.53 MUSD 189.9 M265
Provider of DNA testing services to create a family tree and ancestor
2003Yehud, Central District, IsraelUSD 40 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Gene therapies for rare diseases including retinal dystrophies are developed.
2013Philadelphia, Pennsylvania, United StatesUSD 82.8 MUSD 64.73 M822
Therapeutics for genetic diseases are developed through targeted interventions.
2015Palo Alto, California, United StatesUSD 434.2 MUSD 502.08 M730
Provider of an online genealogy platform offering a host of services
1996Lehi, Utah, United StatesUSD 146.2 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about ComputeGenomics

ComputeGenomics was founded in 2023.

ComputeGenomics is headquartered in Noida, India. It is registered at Noida, Uttar Pradesh, India.

ComputeGenomics has 1 employees.

The primary company behind ComputeGenomics, Computegenomics Private Limited, reported revenue of ₹0.13 Cr for FY 2025, down 36% year on year.

ComputeGenomics, founded in 2023 in Noida, India, focuses on leveraging cutting-edge technology, advancing biotech innovations, genomics analysis, and data processing platforms. A specialized platform for high-throughput genomics data analysis, enabling efficient processing for researchers and enterprises. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.

ComputeGenomics's top competitors include Biomodal, Aligned Bio and Singular Bio.

ComputeGenomics operates through Computegenomics Private Limited.

The legal entities of ComputeGenomics currently have 2 directors, including Himani Kaushik, Kapil Ravi.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available